Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer
Conditions
Cancer Survivor - Stage IA Ovarian Epithelial Cancer - Stage IB Ovarian Epithelial Cancer - Stage IC Ovarian Epithelial Cancer - Stage IIA Ovarian Epithelial Cancer - Stage IIB Ovarian Epithelial Cancer - Stage IIC Ovarian Epithelial Cancer - Stage IIIA Ovarian Epithelial Cancer - Stage IIIB Ovarian Epithelial Cancer - Stage IIIC Ovarian Epithelial Cancer
Conditions: official terms
Neoplasms, Glandular and Epithelial - Ovarian Neoplasms
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Intervention
Name: follow-up care Type: Other
Name: active surveillance Type: Other
Name: questionnaire administration Type: Other
Overall Status
Recruiting
Summary
This pilot clinical trial studies survivorship care planning in supporting quality of life in ovarian cancer survivors following primary treatment. Survivorship care plans have the potential to empower patients and provide them with a plan of care following treatments. Survivorship care planning may support patient's overall well-being and quality of life after treatment of ovarian cancer.
Detailed Description
PRIMARY OBJECTIVES:

I. To assess the feasibility and acceptability of survivorship care planning (SCP) in ovarian cancer.

SECONDARY OBJECTIVES:

I. To develop the infrastructure and strategy for a larger comparative intervention study (National Cancer Institute [NCI] R01).

OUTLINE: Participants are assigned to 1 of 2 arms.

ARM I: Participants receive standard post-treatment care consisting of regular cancer surveillance visits with treating oncologists.

ARM II: Participants complete survivorship care planning in close collaboration with treating oncologists.

After completion of study treatment, participants are followed up at 2 months.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 21 Years
Gender: Female
Criteria: Inclusion Criteria:

- Diagnosis of stage I, II, or III ovarian cancer

- Ability to read or understand English

- All subjects must have the ability to understand and the willingness to sign a written informed consent

Exclusion Criteria:

- Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Location
City of Hope Medical Center
Duarte, California, United States
Status: Recruiting
Contact: Virginia Sun - 800-826-4673 - vsun@coh.org
Start Date
February 2014
Sponsors
City of Hope Medical Center
Source
City of Hope Medical Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page